FDA reschedules Xigris meeting

FDA rescheduled for Oct. 16 an advisory committee meeting for Xigris drotrecogin alfa, a sepsis therapeutic from Eli Lilly (LLY). The Anti-Infective Advisory Committee meeting, originally scheduled fo...